Myostatin (GDF-8) as a key factor linking muscle mass and bone structure
about
Endocrine crosstalk between muscle and boneRole of Irisin on the bone-muscle functional unitEffects of sex steroids on bones and muscles: Similarities, parallels, and putative interactions in health and diseaseBone and muscle: Interactions beyond mechanical.Locomotor activity influences muscle architecture and bone growth but not muscle attachment site morphologyThe effects of hypermuscularity on shoulder morphology in myostatin-deficient miceInsulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.Joint dysfunction and functional decline in middle age myostatin null mice.Therapies for musculoskeletal disease: can we treat two birds with one stone?Functional body composition and related aspects in research on obesity and cachexia: report on the 12th Stock Conference held on 6 and 7 September 2013 in Hamburg, Germany.Forum on bone and skeletal muscle interactions: summary of the proceedings of an ASBMR workshop.Sarcopenia and neurosurgery.The myokine irisin increases cortical bone mass.Biomechanical aspects of the muscle-bone interactionMuscle-bone interactions during fracture healing.High-throughput screening of mouse gene knockouts identifies established and novel skeletal phenotypes.Immunolocalization of myostatin (GDF-8) following musculoskeletal injury and the effects of exogenous myostatin on muscle and bone healing.GEP constitutes a negative feedback loop with MyoD and acts as a novel mediator in controlling skeletal muscle differentiation.Interaction between muscle and bone, and improving the effects of electrical muscle stimulation on amyotrophy and bone loss in a denervation rat model via sciatic neurectomy.Effect of 1 year of an intentional weight loss intervention on bone mineral density in type 2 diabetes: results from the Look AHEAD randomized trial.Differential Bone Loss in Mouse Models of Colon Cancer Cachexia.Skeletal muscle secreted factors prevent glucocorticoid-induced osteocyte apoptosis through activation of β-cateninIrisin promotes osteoblast proliferation and differentiation via activating the MAP kinase signaling pathwaysAdenovirus-mediated GDF-5 promotes the extracellular matrix expression in degenerative nucleus pulposus cells.Associations between body composition and bone density and structure in men and women across the adult age spectrum.Active-resisted stance modulates regional bone mineral density in humans with spinal cord injury.Effects of the activin A-myostatin-follistatin system on aging bone and muscle progenitor cellsConnexin 43 deficiency attenuates loss of trabecular bone and prevents suppression of cortical bone formation during unloading.The skeletal muscle secretome: an emerging player in muscle-bone crosstalkMyostatin (GDF-8) inhibits chondrogenesis and chondrocyte proliferation in vitro by suppressing Sox-9 expressionReduced gravitational loading does not account for the skeletal effect of botulinum toxin-induced muscle inhibition suggesting a direct effect of muscle on boneA role for myokines in muscle-bone interactionsCommon variants at CDKAL1 and KLF9 are associated with body mass index in east Asian populations.A myostatin inhibitor (propeptide-Fc) increases muscle mass and muscle fiber size in aged mice but does not increase bone density or bone strength.Myostatin regulates tissue potency and cardiac calcium-handling proteins.Bone Pain and Muscle Weakness in Cancer Patients.Myostatin inhibits osteoblastic differentiation by suppressing osteocyte-derived exosomal microRNA-218: A novel mechanism in muscle-bone communication.Vitamin D, a modulator of musculoskeletal health in chronic kidney disease.Using CRISPR/Cas9-mediated gene editing to further explore growth and trade-off effects in myostatin-mutated F4 medaka (Oryzias latipes)Inhibition of GDF8 (Myostatin) accelerates bone regeneration in diabetes mellitus type 2
P2860
Q27008987-15F25226-0833-4949-A1C8-859282B43139Q28068422-8B68F30F-5DF5-4EF5-9199-1EEA34D9C395Q28606560-6806AEF0-48C4-40A3-AF30-5D518CFFBC6DQ28606563-EA22EC95-B548-4602-B655-D27873557DFDQ28652940-68FE22D0-9487-4518-8E90-D518328BC352Q28741035-CCE87D25-CC53-4B0C-B848-3D7D7834F3C0Q33569169-69A22E4E-8F2B-4DFD-B87C-B5550348933BQ33772285-5F2A4D51-1A5A-4DEA-B8FC-A77C7F84BEFCQ33851441-504BC99D-E529-47CB-B638-F9179D802AA6Q33934557-C5BF73CD-FD4A-4F89-A57C-F345C11F08E7Q34344489-A04EB089-406D-4522-9133-CF06FFFCBAF7Q34356360-C5CE5018-0699-4DCD-9A10-A107E6B7F3CDQ34494334-66B278F2-4E72-45FD-9D29-29DA486E76A2Q35014005-B22718E5-384A-4641-9314-F7851D1001DBQ35612050-957CDC9E-493C-41AD-AB03-2F44B2240695Q35755147-5365B362-A771-406D-B929-EB634EAA239FQ35768143-1AD38D1B-D38B-4A41-BC45-D9553306BC5FQ35870668-297F180B-F561-4EBB-84E7-0E291B8C6815Q36001532-0A115BEA-A62D-4E21-BDFF-B552E5309FC8Q36133698-1E999E0B-33D8-4833-ADC4-64C09AF70095Q36260536-93CC2065-6759-4DA9-9A7B-DAD3496A330DQ36356669-7A8BBDAE-8FEC-4D10-A032-019937F4EB44Q36438503-4223CB0B-ACD9-4B80-8E3B-59AD64A21865Q36456967-A22EEF6C-01F2-4C7A-89B0-4CE4570FBBD6Q36553559-5C4CEB59-1A58-4740-B560-8A0DB2832F74Q36845397-F57CF1B1-6EF7-49E3-A5CD-BE6B9B3BFB91Q36919044-6B8AAE76-95DB-46D0-8CE2-9DDA17F41BC3Q36931466-31D0A96F-D965-4A2D-B826-45CF16F9D8CCQ37056395-83BA5E0D-62FF-4242-9DE5-022DA280FF89Q37081618-9E59E74B-C61A-416F-9C0D-1AB442962D54Q37131786-D88B4FB4-A76F-4199-9310-C9381B6A8AD2Q37218921-03DBA208-6C42-4D5E-8A40-9A123F0BCF09Q37338403-0EB31CC4-DA19-4AF9-AADC-7F67AC33BD49Q37595428-81DF026B-12A7-493C-B26B-77587264B1EAQ37709194-44914C58-9C28-455A-B1CD-78FB04BA160FQ38684768-21506A72-B329-4207-923D-E5A1038FF42DQ38705141-88129514-0E78-49EC-A6FB-A55B43AC5887Q39413414-3205D945-7A26-4CEB-9A88-E666A594C740Q41198348-06266913-F67D-46CB-9F2B-2D31415D4E7CQ41550650-A1AEE66B-A3CD-4C33-872F-AFF8ACA378F1
P2860
Myostatin (GDF-8) as a key factor linking muscle mass and bone structure
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Myostatin (GDF-8) as a key factor linking muscle mass and bone structure
@en
Myostatin
@nl
type
label
Myostatin (GDF-8) as a key factor linking muscle mass and bone structure
@en
Myostatin
@nl
prefLabel
Myostatin (GDF-8) as a key factor linking muscle mass and bone structure
@en
Myostatin
@nl
P2860
P1476
Myostatin (GDF-8) as a key factor linking muscle mass and bone structure
@en
P2093
M N Elkasrawy
M W Hamrick
P2860
P577
2010-03-01T00:00:00Z